Crunching the numbers for AXSM... Refresh in a moment for the full analysis.
Axsome Therapeutics, Inc. (AXSM)
mixed
$178.11
Updated: 2026-04-13
45
TradeApes Score
hold
Financial Strength
35
Weak
Operating Trend
65
Healthy
Valuation
40
Weak
Capital Allocation
35
Weak
Risk
50
Mixed
Key Findings
+
Strong revenue growth — sales up more than 20% year over year
−
Weak interest coverage — earnings barely cover debt service
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.